Seropositivity – Page 9 – Communicable Diseases Research

Long-Term Comparison of 7 SARS-CoV-2 Antibody Assays in the North Zealand Covid-19 Cohort

North Zealand Covid-19 코호트에서 7개의 SARS-CoV-2 항체 분석의 장기 비교

Article

Published on 2022-05-042022-09-11
Journal: The journal of applied laboratory medicine [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법,

An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in Turkey

터키 의료 종사자의 코로나백 2차 접종 후 항체 반응 및 BNT162b2 또는 코로나백 추가 접종 후 체액성 반응 분석

Article

Published on 2022-05-012022-09-11
Journal: Journal of medical virology [Category] Fulltext, MERS, 변종, 진단,

[키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration age Analysis Anti-RBD IgG anti-receptor-binding domain antibody antibody levels Antibody Response asked blood draw BNT162b2 booster booster dose booster doses chronic disease circulating variants Complete CoronaVac coronavirus dose evaluated Follow-up groups healthcare worker Healthcare workers Heterologous heterologous vaccination homologous or heterologous humoral Humoral response IgG Immunoglobulin Immunoglobulin G Inactivated vaccine independent predictor independent predictors levels of antibody Limited Messenger RNA Odds ratio participant Participants prospective cohort study Quantitative questionnaire RBD reduction respiratory risk SARS-CoV-2 second dose Seropositivity severe acute respiratory syndrome Coronavirus single booster dose the median Turkey university hospital vaccination Vaccine waning immunity were infected were measured
[DOI] 10.1002/jmv.27620 PMC 바로가기 [Article Type] Article

Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida

플로리다의 암 환자에서 SARS-CoV-2 mRNA-1273 백신 접종에 대한 항체 반응 평가

Article

Published on 2022-05-012022-09-12
Journal: JAMA Oncology [Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] 95% CI age anti-CD20 anti-CD20 treatment antibody Antibody Response applied blood test calculated Cancer cancer diagnosis cancer type cohort study diagnose dose doses English enzyme-linked immunosorbent Factor geometric mean titer hematologic Hispanic IgG IgG level Immunosuppressive treatment individual lowest lymphocyte lymphoid monoclonal antibody treatment morbidity and mortality mRNA-1273 Older outcome participant Patient patients treated Patients with cancer receipt receiving response SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2 vaccine Seroconversion Seropositivity significantly lower small molecule solid tumor Spanish T Test treated Treatment vaccination vaccine dose vaccine response white
[DOI] 10.1001/jamaoncol.2022.0001 PMC 바로가기 [Article Type] Article

Seroepidemiology of SARS-CoV-2 in pediatric population during a 16-month period prior to vaccination

백신 접종 전 16개월 동안 소아 집단에서 SARS-CoV-2의 혈청역학

Article

Published on 2022-05-012022-09-11
Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age antibody Antibody titer Antibody titers children collected Community coronavirus coronavirus disease Coronavirus disease 2019 correlation COVID-19 COVID-19 infection cut-off diagnosed Elecsys Epidemic epidemic waves except for females group groups hospital Hospitalized Immunity immunization Infection investigated Limited lowest male median median age no significant differences nucleocapsid protein pandemic pediatric Randomly reported representing respiratory SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody Seroepidemiology seropositive Seropositivity serum sample serum samples severe acute respiratory syndrome Coronavirus significant difference significantly higher study period Support Total vaccination was related
[DOI] 10.1002/jmv.27608 PMC 바로가기 [Article Type] Article

Antibody response with SARS-CoV-2 inactivated vaccine (CoronaVac) in Turkish geriatric population

터키 노인 인구에서 SARS-CoV-2 비활성화 백신(CoronaVac)에 대한 항체 반응

Article

Published on 2022-05-012022-09-11
Journal: Age and Ageing [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술,

[키워드] affecting Anti-spike anti-Spike IgG Antibody Response association best Charlson Comorbidity Index clinical Comorbidity Comprehensive CoronaVac COVID-19 vaccine defined Factor frailty geriatric assessment group IgG antibodies IgG antibody Inactivated vaccine individual Infection influence knowledge neutralising neutralising antibody Older older people Patient patients performed Prevalence response duration SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike-specific SARS-CoV-2 spike-specific IgG antibodies scale second dose seronegative seropositive Seropositivity significantly higher Sinovac specific IgG antibodies the antibody response the vaccine three group three groups U/mL vaccination
[DOI] 10.1093/ageing/afac088 PMC 바로가기 [Article Type] Article

Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers

SARS-CoV-2 항체의 혈청 유병률 및 6개월 동안 재감염 위험 감소: 44,000명의 의료 종사자를 대상으로 한 덴마크 관찰 코호트 연구

Observational Study

Published on 2022-05-012022-09-12
Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), MERS, SARS, 임상, 진단,

[키워드] 95%CI acute respiratory syndrome antibody Characteristics coronavirus disease Coronavirus-2 COVID COVID-19 ELISA examined HCW HCWs healthcare worker Healthcare workers immune response increased risk infection with SARS-CoV-2 key factor longitudinal change majority Observational cohort study offered Older participant Prospective Study protective effect Questionnaires reduced risk Registered Reinfection remained reported risk risk ratio RRs SARS-CoV-2 SARS-CoV-2 antibody screened seropositive seropositive participants Seropositivity Seroprevalence significantly higher significantly increased significantly lower Symptom
[DOI] 10.1016/j.cmi.2021.09.005 PMC 바로가기 [Article Type] Observational Study

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma

다발성 골수종 환자에서 SARS-CoV-2 mRNA COVID-19 백신에 대한 낮은 임상 보호 반응

Observational Study

Published on 2022-05-012022-09-12
Journal: International journal of hematology [Category] COVID19(2023년), MERS, SARS, 임상, 진단,

[키워드] administration age Analysis anti-CD38 Anti-CD38 antibody antibody antibody production Antibody Response Antibody titer Antibody titers B-cell booster CD19+ Cell clinically conducted coronavirus disease COVID-19 COVID-19 vaccine evaluate evaluated healthy controls IgG immunomodulatory drug Japan lymphocyte lymphopenia mRNA mRNA vaccine much lower Multiple Multiple myeloma Patient patients plasma Plasma cell Plasma cell dyscrasia polyclonal Prevalence Protective protocol receiving SARS-CoV-2 Seropositivity significantly higher significantly lower suggested symptomatic therapy vaccination Vaccine vaccine administration
[DOI] 10.1007/s12185-022-03300-4 PMC 바로가기 [Article Type] Observational Study

Seroprevalence and factors associated with SARS-CoV-2 infection among education workers after the first wave: the first cross-sectional study in Brazil

1차 유행 이후 교육 종사자들 사이에서 SARS-CoV-2 감염과 관련된 혈청 유병률 및 요인: 브라질 최초의 횡단면 연구

Article

Published on 2022-04-292022-09-11
Journal: Revista da Sociedade Brasileira de Medicina Tropic [Category] COVID19(2023년), SARS, 진단, 치료기술,

[키워드] age Asymptomatic asymptomatic individual Asymptomatic individuals Brazil Community conducted COVID-19 COVID-19 pandemic cross-sectional cross-sectional study detectable Factor First wave fraction General population higher education IgG impacted increase in increasing age investigated less much lower pandemic participant participated positive positive result Prevalence professional professionals SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 infections Schools serological survey Serologically seropositive Seropositivity Seroprevalence Sex significantly teacher tested the disease universities women
[DOI] 10.1590/0037-8682-0606-2021 PMC 바로가기 [Article Type] Article

Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response

SARS-CoV-2 항체 반응을 검출하기 위한 핑거 프릭 모세관 건조 혈액 반점 샘플에 대한 면역글로불린 G 혈청학의 성능

Article

Published on 2022-04-272022-09-11
Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술,

[키워드] 95% CI 95% confidence interval Accuracy acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis anti-IgG antibody Blood bootstrap calculate Canada capillary children collected comparable conducted coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 cross-sectional cross-sectional study Data analysis DBS sample DBS samples detect diagnostic Diagnostic accuracy discrimination distributions Dried blood spots Epidemiology evaluate finger Finger prick IgG Immunoglobulin G Infection involved Logistic regression logistic regression model modeling multiplex natural infection operator participant performance Positive predictive value Predictive Predictive value public health Quantitative recipients respiratory response ROC ROC analysis Sample SARS-CoV-2 SARS-COV-2 infection sensitivity Seroconversion serological survey Seropositivity serum serum sample serum samples severe acute respiratory syndrome Coronavirus specificity spot subset tested threshold vaccination Vaccine vaccine dose vaccine evaluation venipuncture were used
[DOI] 10.1128/spectrum.01405-21 PMC 바로가기 [Article Type] Article

Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves

처음 3개의 전염병 파동 동안 태국 성인에서 항 SARS-CoV-2 항체의 혈청 유병률

Article

Published on 2022-04-272022-09-11
Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody assays chemiluminescence immunoassay Community Contact tracing coronavirus coronavirus disease Coronavirus disease-19 country COVID-19 COVID-19 outbreak COVID-19 patient COVID-19 patients delta variant disease onset Disease prevalence driver Epidemic epidemic wave epidemic waves Health IgG IgG antibodies immunofluorescence assay individual individuals infection rate microneutralization N protein Neutralizing antibodies numbers of patient participant patients performed Prevalence Public public transport recruited risk SARS-CoV-2 sera seropositive Seropositivity Seroprevalence serum samples Support tested Thai people the N protein the patient Transport with COVID-19
[DOI] 10.1371/journal.pone.0263316 PMC 바로가기 [Article Type] Article